Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02820363 · ClinicalTrials.gov registry record · NA
Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures
A NA study, sponsored by Bonesupport AB.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT02820363: Completed NA study, sponsored by Bonesupport AB.
NCT02820363 is a NA study that has completed, run by Bonesupport AB. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02820363, a NA study, has completed, sponsored by Bonesupport AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of CERAMENT™\|G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone in the care of subjects with open fractures of the tibial diaphysis.
Primary Outcome
Absence of secondary procedures, absence of infection.
Interventions
- DEVICE CERAMENT|G
- PROCEDURE SOC treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT02820363 record still lists
NCT02820363 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which CERAMENT|G is the first listed.
NCT02820363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02820363 about?
NCT02820363 is a clinical study titled "Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures". The purpose of this study is to demonstrate the safety and effectiveness of CERAMENT™\|G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone in the care of subjects with open fractures of the tibial diaphysis.
What is the current status of trial NCT02820363?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2017-02-14. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT02820363?
The interventions under investigation include: CERAMENT|G (DEVICE), SOC treatment (PROCEDURE).
Who is sponsoring clinical trial NCT02820363?
This trial is sponsored by Bonesupport AB, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02820363's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI